May 15 (Reuters)-
Daiken Medical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 9.75 9.14 10.10 4.95
(+6.7 pct) (+7.0 pct) (+3.6 pct) (+2.6 pct)
Operating 1.44 1.05 1.50 700 mln
(+36.8 pct) (-8.4 pct) (+4.0 pct) (-6.1 pct)
Recurring 1.45 1.05 1.50 700 mln
(+37.6 pct) (-8.6 pct) (+3.4 pct) (-6.7 pct)
Net 988 mln 712 mln 1.03 480 mln
(+38.8 pct) (-14.3 pct) (+4.2 pct) (-10.7 pct)
EPS 34.41 yen 24.79 yen 35.85 yen 16.71 yen
Ann Div 21.00 yen 20.00 yen 22.00 yen
-Q2 Div 9.00 yen 9.00 yen 9.00 yen
-Q4 Div 12.00 yen 11.00 yen 13.00 yen
NOTE - Daiken Medical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7775.T